a three-month forbearance that would drop his payments drastically. The bank told him he should have no problem getting a permanent loan modification.

"It thought, ‘This is like a blessing. This is wonderful,'" Waters said.

But then Waters got a letter in the mail.

"It says we mutually agreed upon a special forbearance, but because the payment has not been received we are canceling it," Waters said. The letter said Waters should have paid by on the 11th day of the month, but he says his payment history specifically says the payment is due on the 26th of the month.

When Waters called Bank of America to get to the bottom of it, he heard a brand new story. He says the bank couldn't offer him a forbearance -- it didn't ownMagazine Article
| June 7, 2017

How Pfizer And Zoetis Launched One Of The Most Successful Spinoffs — Ever

Spinning off a $4 billion biopharma business is no easy task. Integrated functions need to be separated, governance boards created, leadership teams assembled, and corporate headquarters established. And those are just a few of the tasks Pfizer faced when announcing the decision to spin off its animal health business back in 2012. A CEO also needed to be chosen for this soon-to-be, completely independent animal health company.

ENTER JUAN RAMÓN ALAIX.

Since 2006 Alaix had been responsible for managing the Pfizer animal health business, a fact that made him the likely candidate for the new job, except for one thing — he had never been a CEO. That one missing ingredient has been known